• Thu, December 7, 2017
  • Fri, December 8, 2017
  • Tue, December 12, 2017
  • Mon, December 11, 2017

Robert Hazlett Initiated (AKBA) at Strong Buy and Held Target at $30 on, Dec 7th, 2017

Robert Hazlett of BTIG, Initiated "Akebia Therapeutics, Inc." (AKBA) at Strong Buy and Held Target at $30 on, Dec 7th, 2017.

Robert has made no other calls on AKBA in the last 4 months.



There is 1 other peer that has a rating on AKBA. Out of the 1 peers that are also analyzing AKBA, 0 agree with Robert's Rating of Hold.



This is the rating of the analyst that currently disagrees with Robert


  • Difei Yang of "Mizuho" Initiated at Strong Buy and Held Target at $24 on, Thursday, October 5th, 2017